Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses

Journal of Investigative Dermatology

Volumn 114, Issue 2, 2000, Pages 295-302

  Cavani, Andrea ^a   Nasorri, Francesca ^a   Prezzi, Caterina ^a   Sebastiani, Silvia ^a   Albanesi, Cristina ^a   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Allergic contact dermatitis; Interleukin 10; Regulatory T cells

Indexed keywords

CD28 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; GAMMA INTERFERON; HAPTEN; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; NICKEL;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOLECULAR CLONING; NICKEL HYPERSENSITIVITY; PRIORITY JOURNAL; SKIN ALLERGY; TH1 CELL;

EID: 0034045748     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00881.x     Document Type: Article

References (62)

1. Albanesi C, Cavani A, Girolomoni G: IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-γ and TNF-α. J Immunol 162:494-502, 1999
2. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28:359-369, 1998
3. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 102:98-106, 1998
4. + T cells are associated with IFN-γ production. FASEB J 10:769-776, 1996
5. Asada H, Linton J, Katz SI: Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. J Invest Dermatol 108:406-411, 1997
6. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245-252, 1998
7. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D: Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99-108, 1995
8. + T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 111:44-49, 1998
9. + T cells, respectively, mediate and regulate contact sensitivity to dinirrofluorobenzene. Eur J lmmunol 25:3006-3010, 1995
10. + T cell lines, J Exp Med 185:1769-1775, 1997
11. Budinger L, Borradori L, Yee C, et al: Identification and characterization of autoreactive T cell responses to bullous prmphigoid antigen 2 in patients and healthy controls. J Clin Invest 102:2082-2089, 1998
12. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27:756-762, 1997
13. Cavaillon JM, Fitting C, Guinnepain MT, Rassemont R, David B: Lymphocyte proliferative response to the purified Dermatophagoides fannae major allergen in untreated and hyposensitized atopic patients, Allergy 43:146-151, 1988
14. + T cells. J Immunol 154:1232-1238, 1995
15. + T cells. J Invest Dermatol 111:621-628, 1998
16. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
17. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-360, 1993
18. + T cells producing Th2-type cytokines. FASEB J 9:81-86, 1995
19. De Saint-Vis B, Figier-Vivier I, Massacrier C, et al: The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation, J Immunol 160:1666-1676, 1998
20. Diepgen TL, Coenraads PJ: Inflammatory skin diseases II. Contact dermatitis. In: Williams HC, Strachan DP (eds). The Challenge of Dermato-Epidemiology. Boca Raton: CRC Press, 1997, pp. 145-161
21. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224-1234, 1993
22. Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 151:2390-2398, 1993
23. Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J: Induction of hapten-specific tolerance by interleukin-10 in vivo. J Exp Med 179:1397-1402, 1994
24. Ferguson TA, Dube P, Griffith TS: Regulation of contact hypenemitivity by interleukin 10. J Exp Med 179:1597-1604, 1994
25. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
26. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients, J Clin Invest 98:70-77, 1996
27. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144:4121-4128, 1990
28. Grabbe S, Schwarz T: Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37-44, 1998
29. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E: Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19:133-141, 1998
30. + T cells. J Exp Med 184:19-29, 1996
31. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742, 1997
32. + T cells. J Immunol 160:3188-3193, 1998
33. Hostynek JJ, Hinz RS, Lorence CR, Price M, Guy RH: Metals and the skin. Grit Rev Toxicol 23:171-235, 1993
34. + Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-γ or IL-2 determines their function. Int Immunol 8:1287-1294, 1995
35. + T cellmediated contact hypenensitivity. J Exp Med 189:779-786, 1999
36. Kuhn U, Brand P, Willemsen J, et al: Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J Immunol 160:667-673, 1998
37. Lisby S, Hansen LH, Skov L, Menné T, Baadsgaard O: Nickel-induced activation of T cells in individuals with negative patch test to nickel sulphate. Arch Dermatol Res 291:247-252, 1999
38. Morel AS, Quaratino S, Douek DC, Londei M: Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 27:26-34, 1997
39. + cytotoxic T cells from allergic donors. J Invest Dermatol 111:360-366, 1998
40. Muller G, Saloga J, Gernunn T, Schuler G, Knop J, Enk AH: IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J Imtnunot 155:4661-4668, 1995
41. + T cells by IL-4 and IFN-γ. J Immunol 158:2090-2098, 1997
42. O'Farrell AM, Liu Y, Moore KW, Mui AL: IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3- dependcnt and -independent pathways. EMBO J 17:1006-1018, 1998
43. Ohmen JD, Hanifin JM, Nickoloff BJ, et al: Overexpression of IL-10 in atopic dermatis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154:1956-1963, 1995
44. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187, 1990
45. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G: Granulocyte/macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 99:3009-3017, 1997
46. Picker LJ, Kishimoto TK, Smith CW, Wamock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349:796-799, 1991
47. Riemann H, Schwarz A, Grabbe S, et al: Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol 156:1799-1803, 1996
48. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825-831, 1997
49. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109-1118, 1994
50. Sallusto F, Quintieri F, Pugliese O, Reale G, Pini C, Di Felice G: T-cell and antibody response to Parietaria judaica allergenic fractions in atopic and non atopic individuals. Allergy 48:37-44, 1993
51. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, Hauser C: Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181:1935-1940, 1995
52. Scala E, Carbonari M, Del Porto P, et al: Lymphocyte activation gene-3 (LAG-3) expression and IFN-γ production are variably coregulated in different human T lymphocyte subpopulations. J Immunol 161:489-493, 1998
53. Schwarz A, Grabbe S, Riemann H, et al: In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103:211-216, 1994
54. Szabo SJ, Dighe AS, Gubler U, Murphy KM: Regulation of the interleukin (IL) -12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 185:817-824, 1997
55. Steinbrink K, Matthias W, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells, J Immunol 159:4772-4780, 1997
56. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T-cell growth. Blood 81:2964-2971, 1993
57. Traidl C, Jugert F, Krieg T, Merk HF, Hunzelmann N: Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 112:476-482, 1999
58. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
59. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765, 1993
60. Werfel T, Hentschel M, Knapp A, Renz H: Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted Vβ repertoire in nickelmediated contact dennatitis. J Immunol 158:2500-2505, 1997
61. Willheim M, Ebner C, Baier K, et al: Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T (H1) subsets. J Allergy Clin Immunol 100:348-355, 1997
62. + T cells. J Exp Med 183:1001-1012, 1996